Enhancement of bone formation in an experimental bony defect using ferumoxide-labelled mesenchymal stromal cells and a magnetic targeting system.
Oshima
S
S
Department of Orthopaedic Surgery, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, Japan. seigo1224oshima@yahoo.co.jp
Ishikawa
M
M
Mochizuki
Y
Y
Kobayashi
T
T
Yasunaga
Y
Y
Ochi
M
M
D000818:Animals; D001672:Biocompatible Materials / Q000627:therapeutic use; D018786:Bone Substitutes / Q000627:therapeutic use; D018929:Cell Culture Techniques; D002465:Cell Movement; D002516:Ceramics / Q000627:therapeutic use; D003911:Dextrans; D004195:Disease Models, Animal; D017886:Durapatite / Q000627:therapeutic use; D017102:Fracture Healing; D008280:Magnetics; D058185:Magnetite Nanoparticles; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D010012:Osteogenesis / Q000502:physiology*; D011817:Rabbits; D011859:Radiography; D017154:Stromal Cells / Q000637:transplantation; D014458:Ulna Fractures / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*
D001672:Biocompatible Materials; D018786:Bone Substitutes; D003911:Dextrans; D058185:Magnetite Nanoparticles; D017886:Durapatite; C065507:ferumoxides